Stay updated on Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added `Revision: v3.3.2` and removed `Revision: v3.2.0`.
    Difference
    0.1%
    Check dated 2025-11-25T13:43:17.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Notice about potential delays due to a lapse in government funding and related operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:23:58.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    No significant changes to the study page were detected; core details such as the title, phase, eligibility criteria, and locations remain unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:04:44.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    3%
    Check dated 2025-10-06T08:24:13.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T05:09:23.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.2%
    Check dated 2025-09-14T23:06:13.000Z thumbnail image

Stay in the know with updates to Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.